|
시장보고서
상품코드
1558383
오가노이드 서비스 시장 규모 및 예측, 세계 및 지역 점유율, 동향, 성장 기회 분석 보고서 : 유형별, 용도별, 공급원별, 지역별Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography |
||||||
오가노이드 서비스 시장은 2023년 30억 3,000만 달러에서 성장하며, 2031년에는 150억 1,000만 달러에 달할 것으로 예측되며, 2023-2031년 22.3%의 CAGR을 기록할 것으로 예측됩니다. 오가노이드 서비스 시장의 성장 요인으로는 신규 약물 스크리닝 서비스에 대한 수요 증가와 맞춤형 약물의 인기 증가가 꼽힙니다. 그러나 숙련된 전문가 부족과 엄격한 안전 규제가 시장 성장의 걸림돌로 작용하고 있습니다.
오가노이드는 간단한 조직공학 세포 기반 체외 모델로서, 해당 생체내 조직의 복잡한 구조와 기능의 많은 측면을 재현합니다. 또한 진단, 질병 모델, 신약 개발 및 맞춤형 의료에도 사용할 수 있습니다.
북미가 오가노이드 서비스 시장을 주도하고 있습니다. 2023년 2월, Molecular Devices, LLC.와 HUB Organoids(HUB)는 전임상부터 임상까지의 약물 감소를 단계적으로 감소시키는 차세대 3D 생물학 기술 개발을 위한 전략적 제휴를 발표했습니다. 전략적 제휴를 발표했습니다. 또한 연구개발 활동 증가, 조직공학 및 장기 이식에 대한 수요 증가, 높은 오가노이드 도입률이 국내 오가노이드 서비스 시장을 주도하고 있습니다. 오가노이드는 생물 의학 연구와 관련된 몇 가지 한계를 극복할 수 있는 잠재력을 가지고 있으며, 연구자들이 인간 발생에 대한 기계론적 인사이트을 얻고, 인간 질병에 대한 정확한 모델을 만들고, 재생 의료를 위한 환자 맞춤형 조직 소스를 생성하는 데 높은 관심을 보이고 있습니다. 관심이 높아지고 있습니다. 아시아태평양은 2023-2031년 가장 높은 CAGR을 나타낼 것으로 예상됩니다.
신흥 국가 시장의 주요 발전은 향후 시장 기회를 가져올 것입니다.
헬스케어의 발전으로 인해 전 세계에서 오가노이드에 대한 수요가 증가하고 있습니다. 이러한 수요 증가는 세계 차원의 신제품 개발, 인수, 제휴, 제품 출시 및 승인에 기여하고 있습니다. 주요 시장 참여자들은 효율적인 서비스 및 제품 혁신과 개척을 보장하기 위해 노력하고 있습니다. 최근 몇 가지 주요 동향은 다음과 같습니다.
2024년 6월, Molecular Devices, LLC.는 영국 카디프에 전용 시설을 정식으로 오픈했습니다. 수백만 파운드가 투자된 이 시설은 분자디바이스의 독자적인 바이오프로세스 워크플로우와 혁신적인 바이오리액터 기술을 위해 설계되어 PDO를 대규모로 품질관리된 방식으로 생산할 수 있도록 설계되었으며, 3D 대응이 가능하고 재현성이 높은 PDO를 대량으로 맞춤형 서비스로 제공하고 분석에 적합한 형태로 분석에 적합한 형태로 냉동 보존할 수 있습니다. 연구자들은 필요에 따라 이들 제품을 해동, 플레이트화하여 사용할 수 있습니다.
2024년 5월, 생명공학 기업 InSphero는 프랑크푸르트의 Genome Biologics와 파트너십 계약을 체결했습니다. 이번 파트너십을 통해 InSphero는 Genome Biologics의 3D 심장 오가노이드 플랫폼을 상용화할 수 있는 독점적 세계 독점권을 획득하게 됩니다. 이 플랫폼은 새로운 치료법을 개발하기 위한 정확하고 확장 가능한 질병 특이적 오가노이드 모델을 제공하여 심장병 연구의 최전선에 서게 될 것입니다.
2023년 7월, Molecular Devices는 고처리량 용도를 위한 독자적인 바이오프로세스 기술을 이용한 맞춤형 유기체 라인 확장 서비스를 시작했습니다.
2023년 2월, Molecular Devices, LLC.와 HUB Organoids(HUB)는 전략적 제휴를 발표하고 전임상부터 임상까지의 약물 감소를 단계적으로 감소시키는 차세대 3D 생물학 기술의 지속적인 개발에 기여할 것이라고 밝혔습니다.
지난 12월 Molecular Devices, LLC.는 Cellellesce Ltd.를 인수했습니다. 이번 인수는 위탁 개발 및 제조 서비스를 통해 약물 스크리닝을 포함한 다양한 목적의 대규모 PDO 제조에 초점을 맞추었습니다.
2021년 8월, STEMCELL Technologies와 Hubrecht Organoid Technology(HUB)는 계약을 체결했습니다. 이 계약의 일환으로 STEMCELL의 계약 분석 서비스 부문은 전임상 독성학 스크리닝 및 비항암제 개발 서비스를 위해 폐, 장, 간 등 조직 유래 오가노이드를 HUB에 제공하기 시작했습니다. 이러한 서비스는 연구자 및 신약 개발 조직이 전임상시험 프로그램에 오가노이드를 통합하여 새로운 치료법을 신속하고 경제적으로 출시할 수 있도록 돕습니다.
이러한 주요 발전, 시장 진입 및 시장 기업 간의 전략적 제휴는 유기체 서비스 시장 성장에 충분한 기회를 창출할 것입니다.
용도별 인사이트
용도별로는 발생생물학, 감염병 병리학, 재생의료, 약물 독성 및 유효성 시험, 신약개발 및 맞춤의료, 기타로 구분됩니다. 발생생물학 질환 분야는 2023년에 가장 큰 시장 점유율을 차지할 것으로 예상되며, 2023-2031년 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
공급원 기반 인사이트
오가노이드 서비스 시장은 공급원에 따라 다능성 줄기세포와 장기특이적 성체줄기세포로 구분되며, 2023년 시장에서는 다능성 줄기세포 부문이 큰 비중을 차지할 것으로 예상됩니다. 다능성 줄기세포 부문은 예측 기간 중 높은 CAGR을 나타낼 것으로 예상됩니다.
오가노이드 서비스 시장 경쟁 구도 및 주요 발전
Sino Biological Inc., Eurofins Scientific SE, Molecular Devices, LLC, InSphero, Cyprio, InnoSer, LABTOO, CUSABIO TECHNOLOGY LLC, Oncodesign Services, HUB Organoids B.V.(Hubrecht Organoid Technology) 등이 오가노이드 서비스 시장에서 사업을 운영하는 주요 기업입니다.
미국 식품의약국, 미국 질병통제예방센터(CDC), 세계 질병부담연구(Global Burden of Disease Study) 등은 유기체 서비스 시장 보고서를 작성할 때 참고한 1차 및 2차 정보입니다.
목차
제1장 서론
제2장 개요
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 오가노이드 서비스 시장 구도
- PEST 분석
제5장 오가노이드 서비스 시장 : 주요 시장 역학
- 유기 장기 서비스 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 혁신적인 약물 스크리닝 서비스에 대한 수요의 증가
- 맞춤형 의약품의 급증
- 시장 성장 억제요인
- 숙련 전문가의 부족
- 시장 기회
- 주요 발전의 증가
- 향후 동향
- 인공지능의 통합
- 촉진요인과 억제요인의 영향
제6장 오가노이드 서비스 시장 : 세계 시장 분석
- 오가노이드 서비스 시장 매출, 2021-2031년
- 오가노이드 서비스 시장 예측 분석
제7장 오가노이드 서비스 시장 분석 : 유형별
- 장
- 간
- 위
- 췌장
- 폐
- 뇌
- 신장
- 기타
제8장 오가노이드 서비스 시장 분석 : 용도별
- 발생생물학 질환
- 감염증 병리
- 재생의료
- 의약품 독성·유효성 시험
- Drug Discovery 및 맞춤형 의료
- 기타
제9장 오가노이드 서비스 시장 분석 : 공급원별
- 다능성 줄기세포
- 장기 특이적 성체 줄기세포
제10장 오가노이드 서비스 시장 : 지역별 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- APAC 기타 국가
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제11장 업계 상황
- 오가노이드 서비스 시장에서 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
- 성장 전략
제12장 기업 개요
- Sino Biological Inc.
- Eurofins Scientific SE
- Molecular Devices, LLC.
- InSphero
- Cyprio
- InnoSer
- LABTOO
- CUSABIO TECHNOLOGY LLC
- Oncodesign Services
- HUB Organoids B.V.(Hubrecht Organoid Technology)
제13장 부록
KSA 24.10.10According to our new research study on "Organoids Services Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.3% during 2023-2031. Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.
Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.
North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.
Increasing Key Developments to Provide Market Opportunities in Future
The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:
In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.
In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.
In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.
In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.
In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.
In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.
Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth..
Application -Based Insights
By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.
Source -Based Insights
Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.
Organoids services Market: Competitive Landscape and Key Developments
Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids services market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids services market report.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Organoids Services Market Landscape
- 4.1 PEST Analysis
5. Organoids Services Market - Key Market Dynamics
- 5.1 Organoids Services Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increasing Demand for Innovative Drug Screening Services
- 5.2.2 Surge in Popularity of Personalized Drugs
- 5.3 Market Restraints
- 5.3.1 Dearth of Skilled Professionals
- 5.4 Market Opportunities
- 5.4.1 Increasing Key Developments
- 5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence
- 5.6 Impact of Drivers and Restraints:
6. Organoids Services Market - Global Market Analysis
- 6.1 Organoids Services Market Revenue (US$ Million), 2021-2031
- 6.2 Organoids Services Market Forecast Analysis
7. Organoids Services Market Analysis - by Type
- 7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
8. Organoids Services Market Analysis - by Application
- 8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
9. Organoids Services Market Analysis - by Source
- 9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
10. Organoids Services Market - Geographical Analysis
- 10.1 Overview
- 10.2 North America
- 10.2.1 North America Organoids Services Market Overview
- 10.2.2 North America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Organoids Services Market Breakdown, by Type
- 10.2.3.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.2.4 North America: Organoids Services Market Breakdown, by Application
- 10.2.4.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.2.5 North America: Organoids Services Market Breakdown, by Source
- 10.2.5.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.2.6 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.2.6.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.2.6.2 United States: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
- 10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
- 10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
- 10.2.6.3 Canada: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
- 10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
- 10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
- 10.2.6.4 Mexico: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
- 10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
- 10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
- 10.3 Europe
- 10.3.1 Europe Organoids Services Market Overview
- 10.3.2 Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Organoids Services Market Breakdown, by Type
- 10.3.3.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.3.4 Europe: Organoids Services Market Breakdown, by Application
- 10.3.4.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.3.5 Europe: Organoids Services Market Breakdown, by Source
- 10.3.5.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.3.6 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.3.6.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.3.6.2 Germany: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
- 10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
- 10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
- 10.3.6.3 United Kingdom: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
- 10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
- 10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
- 10.3.6.4 France: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
- 10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
- 10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
- 10.3.6.5 Italy: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
- 10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
- 10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
- 10.3.6.6 Spain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
- 10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
- 10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
- 10.3.6.7 Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
- 10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
- 10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific Organoids Services Market Overview
- 10.4.2 Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
- 10.4.3.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
- 10.4.4.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
- 10.4.5.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.4.6 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.4.6.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.4.6.2 Japan: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
- 10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
- 10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
- 10.4.6.3 China: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
- 10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
- 10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
- 10.4.6.4 India: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
- 10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
- 10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
- 10.4.6.5 South Korea: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
- 10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
- 10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
- 10.4.6.6 Australia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
- 10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
- 10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
- 10.4.6.7 Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
- 10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
- 10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
- 10.5 Middle East and Africa
- 10.5.1 Middle East and Africa Organoids Services Market Overview
- 10.5.2 Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
- 10.5.3.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
- 10.5.4.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
- 10.5.5.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.5.6 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.5.6.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.5.6.2 Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
- 10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
- 10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
- 10.5.6.3 South Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
- 10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
- 10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
- 10.5.6.4 United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
- 10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
- 10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
- 10.5.6.5 Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
- 10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
- 10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
- 10.6 South and Central America
- 10.6.1 South and Central America Organoids Services Market Overview
- 10.6.2 South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
- 10.6.3.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Type
- 10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
- 10.6.4.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Application
- 10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
- 10.6.5.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Source
- 10.6.6 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.6.6.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.6.6.2 Brazil: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
- 10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
- 10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
- 10.6.6.3 Argentina: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
- 10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
- 10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
- 10.6.6.4 Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
- 10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
- 10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source
11. Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in Organoids Services Market
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 11.4 Inorganic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Sino Biological Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Molecular Devices, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 InSphero
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Cyprio
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 InnoSer
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 LABTOO
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 CUSABIO TECHNOLOGY LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Oncodesign Services
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
